A detailed history of Dimensional Fund Advisors LP transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 46,664 shares of SPRB stock, worth $24,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,664
Holding current value
$24,265
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$0.7 - $5.49 $32,664 - $256,185
46,664 New
46,664 $36,000
Q3 2023

Nov 09, 2023

BUY
$2.04 - $2.54 $24 - $30
12 Added 0.04%
32,452 $73,000
Q2 2023

Aug 09, 2023

SELL
$1.92 - $2.6 $12,917 - $17,492
-6,728 Reduced 17.18%
32,440 $69,000
Q1 2023

May 12, 2023

BUY
$1.15 - $3.17 $33,243 - $91,635
28,907 Added 281.72%
39,168 $86,000
Q4 2022

Feb 09, 2023

SELL
$0.99 - $1.19 $1,528 - $1,837
-1,544 Reduced 13.08%
10,261 $11,000
Q3 2022

Nov 10, 2022

BUY
$1.37 - $2.19 $16,172 - $25,852
11,805 New
11,805 $16,000

Others Institutions Holding SPRB

About SPRUCE BIOSCIENCES, INC.


  • Ticker SPRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,560,200
  • Market Cap $12.3M
  • Description
  • Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...
More about SPRB
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.